Naslov
Analytical issues in lipoprotein (a) determination and their impact on assessing the therapeutic effect

Autori
Šparakl, Tajana ; Šegulja, Dragana ; Rogić, Dunja

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Poster Abstracts : EuroMedLab Munich 2021 : Atherosclerosis, including lipids and other risk markers, Clinical Chemistry and Laboratory Medicine (CCLM), 59, S1 / - : Walter de Gruyter, 2021

Skup
24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedlab 2021)

Mjesto i datum
München, Njemačka, 10.04.2022. - 14.04.2022

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Lipoprotein (a) ; atherosclerosis ; harmonization

Sažetak
Lp(a) is recognized by professional associations such as ESC/EAS, HEART UK, EAS/EFLM (for LDLC correction) as a cardiovascular disease risk factor. Although Lp(a) molecules have a highly heterogeneous structure and the ratio of mass to molar concentration varies between individuals, recommendations present Lp(a) levels in different units and some additionally suggest arbitrary conversion coefficients. Furthermore, the analytical method and measuring system used can alter the follow-up of the applied therapeutic approach such as apheresis or innovative medications that selectively target Lp(a). The aim of this study was to compare Lp(a) results on two different analytical platforms.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti, Farmacija

POVEZANOST RADA